About XCellCure
XCellCure is a company based in St. Louis (United States) founded in 2010. It operates as a B2B. XCellCure offers products and services including AMiAware Cardiac Panel and Living Healthy Products. XCellCure operates in a competitive market with competitors including Conavi, Acarix, Infraredx, Ionetix and Cleveland HeartLab, among others.
- Headquarter St. Louis, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Xcellcure, Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of XCellCure
XCellCure offers a comprehensive portfolio of products and services, including AMiAware Cardiac Panel and Living Healthy Products. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides biomarkers for predicting heart attacks and guiding personalized therapies.
Offers tools for detecting and predicting cardiovascular risks in patients.
Unlock access to complete
Unlock access to complete
Funding Insights of XCellCure
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by XCellCure
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - XCellCure
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Xcellcure Comparisons
Competitors of XCellCure
XCellCure operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Conavi, Acarix, Infraredx, Ionetix and Cleveland HeartLab, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Catheter-based ultrasound systems for cardiac imaging are developed.
|
|
| domain | founded_year | HQ Location |
A screening device for acoustic coronary artery diseases is provided.
|
|
| domain | founded_year | HQ Location |
Coronary imaging and plaque detection system
|
|
| domain | founded_year | HQ Location |
Superconducting cyclotrons for PET radioisotopes are developed by Ionetix.
|
|
| domain | founded_year | HQ Location |
Cardiovascular biomarkers are utilized for disease prevention and management.
|
|
| domain | founded_year | HQ Location |
Apo J-Glyc biomarker is commercialized for cardiac ischemia diagnosis.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about XCellCure
When was XCellCure founded?
XCellCure was founded in 2010.
Where is XCellCure located?
XCellCure is headquartered in St. Louis, United States. It is registered at St. Louis, Missouri, United States.
What does XCellCure do?
XCellCure is a biotechnology startup that develops and sells cardiac panels with prognostic biomarkers for predicting heart attacks. These products enable physicians to provide personalized medical interventions, reducing cardiovascular risks. Based in St. Louis, Missouri, USA, the company focuses on noninvasive diagnostics and aims to improve acute coronary care through accurate, rapid testing. It targets healthcare providers to enhance patient outcomes and prevent fatalities.
Who are the top competitors of XCellCure?
What products or services does XCellCure offer?
XCellCure offers AMiAware Cardiac Panel and Living Healthy Products.